Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Ionis Pharmaceuticals key operating metrics including Marketed Medicines, environmental, and social and governance score (ESG).

Marketed Medicines

6
20.0%

FY, 2024

Phase II Trials Products

18
38.5%

FY, 2024

Phase III Trials Products

17
88.9%

FY, 2024

Operating Metrics

MetricsFY, 2022FY, 2023FY, 2024
Marketed Medicines356
Phase II Trials Products161318
Phase III Trials Products7917
Phase I Trials Products1

Environmental, Social and Governance (ESG)

Overall

50-59 out of 100

Community

Employees

Environment

Governance

Premium Content only available in Craft’s Intelligence Portal
Learn more

Source:CSRHub

Footer menu